• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力患者肝素诱导的血小板减少症并发脑静脉窦血栓形成:一例罕见且复杂的病例。

Cerebral venous sinus thrombosis as a complication of heparin-induced thrombocytopenia in myasthenia gravis: A rare and complex case.

作者信息

AbuAlrob Majd A, Gumander Abdullah Mantawil, Zammar Khaled, Qazakzeh Abdullah I Al, Alnakhala Sadi Y, Khalil Osama M, Hussain Suhail

机构信息

Neuroscience Institute, Hamad Medical Corporation, Doha, Qatar.

Department of Medicine, Hamad General Hospital, Doha, Qatar *Email:

出版信息

Qatar Med J. 2025 Jun 9;2025(2):59. doi: 10.5339/qmj.2025.59. eCollection 2025.

DOI:10.5339/qmj.2025.59
PMID:40556853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12183653/
Abstract

BACKGROUND

Cerebral venous sinus thrombosis (CVST) is an uncommon yet critical complication, especially when arising from heparin-induced thrombocytopenia (HIT). In patients with preexisting conditions such as myasthenia gravis (MG), this correlation adds further complexity to clinical management and outcomes.

CASE PRESENTATION

We report a unique case of CVST induced by HIT in a patient with an established diagnosis of MG. Following plasma exchange therapy, which included heparin administration, the patient developed symptoms indicative of CVST. Diagnostic imaging confirmed thrombosis in the cerebral venous sinuses. Management involved the immediate discontinuation of heparin and the initiation of fondaparinux, leading to effective anticoagulation and clinical improvement.

DISCUSSION

This case illustrates the rare intersection of CVST and HIT within the context of MG, underscoring the potential risks associated with heparin therapy in vulnerable patient populations. Early recognition of the signs is essential, as these conditions, in combination, demand prompt and specialized interventions to prevent serious complications.

CONCLUSION

The successful management of this complex case demonstrates the importance of heightened awareness and proactive strategies in patients with MG undergoing heparin therapy. This report advocates for careful monitoring and tailored treatment to mitigate risks in similarly complex clinical scenarios.

摘要

背景

脑静脉窦血栓形成(CVST)是一种罕见但严重的并发症,尤其是由肝素诱导的血小板减少症(HIT)引起时。在患有重症肌无力(MG)等基础疾病的患者中,这种关联给临床管理和预后增加了进一步的复杂性。

病例报告

我们报告了一例确诊为MG的患者发生HIT诱导的CVST的独特病例。在包括肝素给药的血浆置换治疗后,患者出现了提示CVST的症状。诊断性影像学检查证实了脑静脉窦血栓形成。治疗包括立即停用肝素并开始使用磺达肝癸钠,从而实现了有效的抗凝并使临床症状改善。

讨论

该病例说明了在MG背景下CVST与HIT的罕见交集,强调了在脆弱患者群体中肝素治疗相关的潜在风险。早期识别症状至关重要,因为这些情况同时出现需要迅速和专业的干预以预防严重并发症。

结论

该复杂病例的成功管理证明了在接受肝素治疗的MG患者中提高认识和采取积极策略的重要性。本报告提倡仔细监测和量身定制治疗方案,以降低类似复杂临床情况下的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12183653/59708ff3c158/qmj-2025-02-059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12183653/a3249388bd7c/qmj-2025-02-059-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12183653/59708ff3c158/qmj-2025-02-059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12183653/a3249388bd7c/qmj-2025-02-059-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56d3/12183653/59708ff3c158/qmj-2025-02-059-g002.jpg

相似文献

1
Cerebral venous sinus thrombosis as a complication of heparin-induced thrombocytopenia in myasthenia gravis: A rare and complex case.重症肌无力患者肝素诱导的血小板减少症并发脑静脉窦血栓形成:一例罕见且复杂的病例。
Qatar Med J. 2025 Jun 9;2025(2):59. doi: 10.5339/qmj.2025.59. eCollection 2025.
2
Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.普通肝素与低分子量肝素用于预防术后患者肝素诱导的血小板减少症的比较
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD007557. doi: 10.1002/14651858.CD007557.pub3.
3
Pentasaccharides for the treatment of deep vein thrombosis.用于治疗深静脉血栓形成的五糖。
Cochrane Database Syst Rev. 2017 Dec 2;12(12):CD011782. doi: 10.1002/14651858.CD011782.pub2.
4
Assessing the symptom control provided by ravulizumab or efgartigimod in myasthenia gravis: an evaluation of the patient experience of two different treatment approaches.评估ravulizumab或efgartigimod对重症肌无力症状的控制:两种不同治疗方法的患者体验评估
Curr Med Res Opin. 2025 May;41(5):817-827. doi: 10.1080/03007995.2025.2497906. Epub 2025 May 24.
5
Home versus in-patient treatment for deep vein thrombosis.深静脉血栓形成的家庭治疗与住院治疗对比
Cochrane Database Syst Rev. 2018 Jan 9;1(1):CD003076. doi: 10.1002/14651858.CD003076.pub3.
6
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.药物干预预防接受减重手术人群的静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.全身性治疗史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)和 SJS/TEN 重叠综合征。
Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.
9
Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.预防抗生素用于预防与成人和儿童癌症治疗期间长期使用中心静脉导管相关的革兰氏阳性感染。
Cochrane Database Syst Rev. 2021 Oct 7;10(10):CD003295. doi: 10.1002/14651858.CD003295.pub4.
10
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.皮下注射普通肝素用于静脉血栓栓塞症的初始治疗。
Cochrane Database Syst Rev. 2017 Feb 14;2(2):CD006771. doi: 10.1002/14651858.CD006771.pub3.

本文引用的文献

1
Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review.直接口服抗凝剂治疗 HIT:汉密尔顿经验更新及文献回顾。
Blood. 2017 Aug 31;130(9):1104-1113. doi: 10.1182/blood-2017-04-778993. Epub 2017 Jun 23.
2
Heparin-Induced Thrombocytopenia.肝素诱导的血小板减少症
N Engl J Med. 2015 Nov 5;373(19):1883-4. doi: 10.1056/NEJMc1510993.
3
Heparin induced thrombocytopenia.肝素诱导的血小板减少症。
BMJ. 2015 Jan 8;350:g7566. doi: 10.1136/bmj.g7566.
4
Nonheparin anticoagulants for heparin-induced thrombocytopenia.用于肝素诱导的血小板减少症的非肝素抗凝剂。
N Engl J Med. 2013 Feb 21;368(8):737-44. doi: 10.1056/NEJMct1206642.
5
Anticoagulation for cerebral venous sinus thrombosis.脑静脉窦血栓形成的抗凝治疗
Stroke. 2012 Apr;43(4):e41-e42. doi: 10.1161/strokeaha.111.648162.
6
HIT paradigms and paradoxes.HIT 范式和悖论。
J Thromb Haemost. 2011 Jul;9 Suppl 1:105-17. doi: 10.1111/j.1538-7836.2011.04322.x.
7
Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association.脑静脉血栓形成的诊断和治疗:美国心脏协会/美国中风协会向医疗保健专业人员的声明。
Stroke. 2011 Apr;42(4):1158-92. doi: 10.1161/STR.0b013e31820a8364. Epub 2011 Feb 3.
8
Cerebral venous sinus (sinovenous) thrombosis in children.儿童脑静脉窦(静脉)血栓形成。
Neurosurg Clin N Am. 2010 Jul;21(3):511-27. doi: 10.1016/j.nec.2010.03.006.
9
EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients.EFNS 成人颅内静脉和静脉窦血栓形成治疗指南。
Eur J Neurol. 2010 Oct;17(10):1229-35. doi: 10.1111/j.1468-1331.2010.03011.x.
10
Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.肝素诱导的血小板减少症:一种通过动态自身抗原组装/拆卸调节的自身免疫性疾病。
J Clin Apher. 2007 Feb;22(1):31-6. doi: 10.1002/jca.20109.